Zynerba Pharmaceuticals Shares Halted, News Pending
Portfolio Pulse from Benzinga Newsdesk
Trading of shares in Zynerba Pharmaceuticals has been halted pending an announcement of news.
August 14, 2023 | 11:26 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Zynerba Pharmaceuticals' shares have been halted from trading, pending an announcement of news. This could potentially impact the company's stock price.
The trading halt indicates that there is significant news pending that could affect the company's stock price. Until the nature of the news is known, it's difficult to predict the direction of the impact.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100